Latest Breaking News On - Centre for neuropsychiatric schizophrenia research - Page 1 : comparemela.com

Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002

/PRNewswire/ Gabather AB (Nasdaq First North Growth Market: GABA) announces that the Company has signed a Collaborative Agreement with the Centre for.

Michael robin wittPsychiatric centre in glostrupInnovation fund denmarkCentre for neuropsychiatric schizophrenia researchNasdaq first north growth marketCollaborative agreementNeuropsychiatric schizophrenia researchPsychiatric centreInvestment agreementPositive allosteric modulatorRobin wittFirst north growth marketCorpura fondkommissionGabather abHealth care amp hospitalsMedical pharmaceuticals

Gabather AB: Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002

Gabather AB: Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Dennis riedlMichael robin wittCentre for neuropsychiatric schizophrenia researchInnovation fund denmarkPsychiatric centre in glostrupNasdaq first north growth marketCollaborative agreementNeuropsychiatric schizophrenia researchPsychiatric centreInvestment agreementPositive allosteric modulatorRobin wittFirst north growth marketCorpura fondkommission